Human Gene GH1 (ENST00000323322.10) from GENCODE V44
  Description: Homo sapiens growth hormone 1 (GH1), transcript variant 1, mRNA. (from RefSeq NM_000515)
RefSeq Summary (NM_000515): The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008].
Gencode Transcript: ENST00000323322.10
Gencode Gene: ENSG00000259384.7
Transcript (Including UTRs)
   Position: hg38 chr17:63,917,203-63,918,839 Size: 1,637 Total Exon Count: 5 Strand: -
Coding Region
   Position: hg38 chr17:63,917,309-63,918,776 Size: 1,468 Coding Exon Count: 5 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr17:63,917,203-63,918,839)mRNA (may differ from genome)Protein (217 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMalacardsMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: SOMA_HUMAN
DESCRIPTION: RecName: Full=Somatotropin; AltName: Full=Growth hormone; Short=GH; Short=GH-N; AltName: Full=Growth hormone 1; AltName: Full=Pituitary growth hormone; Flags: Precursor;
FUNCTION: Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues.
SUBUNIT: Monomer, dimer, trimer, tetramer and pentamer, disulfide- linked or non-covalently associated, in homopolymeric and heteropolymeric combinations. Can also form a complex either with GHBP or with the alpha2-macroglobulin complex.
INTERACTION: P10912:GHR; NbExp=3; IntAct=EBI-1026046, EBI-286316;
SUBCELLULAR LOCATION: Secreted.
DISEASE: Defects in GH1 are a cause of growth hormone deficiency isolated type 1A (IGHD1A) [MIM:262400]; also known as pituitary dwarfism I. IGHD1A is an autosomal recessive deficiency of GH which causes short stature. IGHD1A patients have an absence of GH with severe dwarfism and often develop anti-GH antibodies when given exogenous GH.
DISEASE: Defects in GH1 are a cause of growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781]; also known as dwarfism of Sindh. IGHD1B is an autosomal recessive deficiency of GH which causes short stature. IGHD1B patients have low but detectable levels of GH. Dwarfism is less severe than in IGHD1A and patients usually respond well to exogenous GH.
DISEASE: Defects in GH1 are the cause of Kowarski syndrome (KWKS) [MIM:262650]; also known as pituitary dwarfism VI.
DISEASE: Defects in GH1 are a cause of growth hormone deficiency isolated type 2 (IGHD2) [MIM:173100]. IGHD2 is an autosomal dominant deficiency of GH which causes short stature. Clinical severity is variable. Patients have a positive response and immunologic tolerance to growth hormone therapy.
PHARMACEUTICAL: Available under the names Nutropin or Protropin (Genentech), Norditropin (Novo Nordisk), Genotropin (Pharmacia Upjohn), Humatrope (Eli Lilly) and Saizen or Serostim (Serono). Used for the treatment of growth hormone deficiency and for Turner's syndrome.
MISCELLANEOUS: Circulating GH shows a great heterogeneity due to alternative splicing, differential post-translational modifications of monomeric forms, oligomerization, optional binding to 2 different GH-binding proteins, and potentially proteolytic processing.
SIMILARITY: Belongs to the somatotropin/prolactin family.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/GH1";
WEB RESOURCE: Name=Wikipedia; Note=Growth hormone entry; URL="http://en.wikipedia.org/wiki/Growth_hormone";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: GH1
Diseases sorted by gene-association score: kowarski syndrome* (1678), growth hormone deficiency, isolated, type ii* (1671), growth hormone deficiency, isolated, type ia* (1354), growth hormone deficiency, isolated, type ib* (1105), isolated growth hormone deficiency, type ib, gh1-related* (100), growth hormone deficiency (75), isolated growth hormone deficiency (20), pituitary gland disease (19), fibrous dysplasia/mccune-albright syndrome (19), empty sella syndrome (18), protein-deficiency anemia (16), functioning pituitary adenoma (15), dwarfism (15), acromegaly (15), chromophobe adenoma (14), acid-labile subunit, deficiency of (14), pituitary adenoma (14), non-functioning pituitary adenoma (13), laron dwarfism (13), lymphocytic hypophysitis (12), pituitary tumors (12), hypopituitarism (12), hyperprolactinemia (11), mccune-albright syndrome, somatic, mosaic (11), gigantism (11), adenohypophysitis (10), turner syndrome (10), fibrous dysplasia (10), precocious puberty (10), hypothyroidism, congenital, nongoitrous 4 (10), insulin-like growth factor i (9), tsh producing pituitary tumor (9), gaucher disease, type i (9), syringomyelia (9), gonadal disease (9), hypothalamic disease (8), hyperthyroidism (8), pituitary hormone deficiency, combined, 2 (8), prader-willi syndrome (7), marasmus (7), pituitary adenoma, prolactin-secreting (7), anorexia nervosa (7), acth deficiency (7), hyperpituitarism (7), pituitary stalk interruption syndrome (6), adrenal gland hyperfunction (6), gastroduodenitis (6), aromatase deficiency (6), pituitary adenoma, growth hormone-secreting (5), hypoadrenalism (5), adenoma (5), tetrahydrobiopterin deficiency (5), hypersomnia (5), pituitary adenoma, acth-secreting (4), osteoporosis (2), diabetes mellitus, insulin-dependent (2), obesity (1), diabetes mellitus, noninsulin-dependent (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 32386.90 RPKM in Pituitary
Total median expression: 32409.41 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -16.3063-0.259 Picture PostScript Text
3' UTR -25.00106-0.236 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR009079 - 4_helix_cytokine-like_core
IPR012351 - 4_helix_cytokine_core
IPR001400 - Somatotropin
IPR018116 - Somatotropin_CS

Pfam Domains:
PF00103 - Somatotropin hormone family

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1A22 - X-ray MuPIT 1AXI - X-ray MuPIT 1BP3 - X-ray MuPIT 1HGU - X-ray 1HUW - X-ray MuPIT 1HWG - X-ray MuPIT 1HWH - X-ray MuPIT 1KF9 - X-ray MuPIT 3HHR - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P01241
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsembl   
Protein SequenceProtein SequenceProtein Sequence   
AlignmentAlignmentAlignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005131 growth hormone receptor binding
GO:0005148 prolactin receptor binding
GO:0005179 hormone activity
GO:0005515 protein binding
GO:0008083 growth factor activity
GO:0046872 metal ion binding

Biological Process:
GO:0010469 regulation of receptor activity
GO:0010536 positive regulation of activation of Janus kinase activity
GO:0010828 positive regulation of glucose transport
GO:0014068 positive regulation of phosphatidylinositol 3-kinase signaling
GO:0032355 response to estradiol
GO:0040018 positive regulation of multicellular organism growth
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein
GO:0043406 positive regulation of MAP kinase activity
GO:0043568 positive regulation of insulin-like growth factor receptor signaling pathway
GO:0046427 positive regulation of JAK-STAT cascade
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0060396 growth hormone receptor signaling pathway
GO:0060397 JAK-STAT cascade involved in growth hormone signaling pathway
GO:0070977 bone maturation
GO:0002092 positive regulation of receptor internalization

Cellular Component:
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0031904 endosome lumen
GO:0070195 growth hormone receptor complex


-  Descriptions from all associated GenBank mRNAs
  AK300190 - Homo sapiens cDNA FLJ57085 complete cds, moderately similar to Chorionic somatomammotropin hormone-like 1 precursor.
AF110644 - Homo sapiens growth hormone splice variant mRNA, complete cds.
E00009 - mRNA coding of human pre growth hormone.
A00469 - H.sapiens mRNA for growth hormone.
BC062475 - Homo sapiens growth hormone 1, mRNA (cDNA clone MGC:75439 IMAGE:30393581), complete cds.
BC090045 - Homo sapiens growth hormone 1, mRNA (cDNA clone MGC:111085 IMAGE:30394115), complete cds.
AY613431 - Homo sapiens growth hormone 1 variant 1 (GH1) mRNA, complete cds.
AY613432 - Homo sapiens growth hormone 1 variant 2 (GH1) mRNA, complete cds.
HW649483 - JP 2014523870-A/2: CLEAVABLE LIPIDS.
HW649494 - JP 2014523411-A/2: LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY.
JB074619 - Sequence 2 from Patent WO2012170930.
JB074630 - Sequence 2 from Patent WO2012170889.
JC570528 - Sequence 2 from Patent WO2014089486.
JE995100 - Sequence 3 from Patent EP2859102.
LQ790603 - Sequence 2 from Patent EP3336082.
LQ850109 - Sequence 2 from Patent EP3354644.
MA155776 - JP 2017014278-A/2: LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY.
MA156904 - JP 2017019857-A/2: CLEAVABLE LIPIDS.
V00519 - Human messenger RNA for growth hormone (presomatotropin).
AF185611 - Homo sapiens growth hormone variant (GHV) mRNA, complete cds.
JD539437 - Sequence 520461 from Patent EP1572962.
JD081366 - Sequence 62390 from Patent EP1572962.
JD124037 - Sequence 105061 from Patent EP1572962.
A00501 - H.sapiens mRNA for human growth hormone.
BC075012 - Homo sapiens growth hormone 1, transcript variant 1, mRNA (cDNA clone MGC:103996 IMAGE:30915404), complete cds.
BC075013 - Homo sapiens growth hormone 1, mRNA (cDNA clone MGC:104157 IMAGE:30915617), complete cds.
E01123 - cDNA encoding human growth hormone derivatie.
E01441 - cDNA encoding human growth hormone 20k.
AB591020 - Synthetic construct DNA, clone: pFN21AB6977, Homo sapiens GH1 gene for growth hormone 1, without stop codon, in Flexi system.
E01424 - DNA sequence of human growth hormone.
JD139918 - Sequence 120942 from Patent EP1572962.
JD131309 - Sequence 112333 from Patent EP1572962.
M14398 - Human precursor growth hormone mRNA, 5' end.
JD438164 - Sequence 419188 from Patent EP1572962.
JD438163 - Sequence 419187 from Patent EP1572962.
JD256206 - Sequence 237230 from Patent EP1572962.
JD324980 - Sequence 306004 from Patent EP1572962.
MA890445 - JP 2017203045-A/2: LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY.
MB447293 - JP 2018141006-A/2: CLEAVABLE LIPIDS.
MP325249 - Sequence 3 from Patent EP3536787.
MP440715 - Sequence 2 from Patent EP3586861.
MP559896 - Sequence 2 from Patent EP3628335.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04060 - Cytokine-cytokine receptor interaction
hsa04080 - Neuroactive ligand-receptor interaction
hsa04630 - Jak-STAT signaling pathway

BioCarta from NCI Cancer Genome Anatomy Project
h_ghPathway - Growth Hormone Signaling Pathway
h_tffPathway - Trefoil Factors Initiate Mucosal Healing
h_ghrelinPathway - Ghrelin: Regulation of Food Intake and Energy Homeostasis
h_aktPathway - AKT Signaling Pathway
h_longevityPathway - The IGF-1 Receptor and Longevity

Reactome (by CSHL, EBI, and GO)

Protein P01241 (Reactome details) participates in the following event(s):

R-HSA-982778 Growth hormone binds the growth hormone receptor
R-HSA-1362485 GHBP binds GH
R-HSA-1168456 Growth hormone receptor binds Lyn
R-HSA-982807 JAK2 phosphorylation of GHR
R-HSA-1168768 JAK2 binds STAT1/3
R-HSA-1168393 STAT5 association with GHR
R-HSA-1168445 PTP1B binds the GH receptor complex
R-HSA-1168809 SOCS binding to GHR
R-HSA-1168813 SOCS binding to JAK2
R-HSA-1168839 SHP1 (PTPN6) binds JAK2 in the receptor complex
R-HSA-1168894 p-STAT5A/B dissociates from the Growth Hormone receptor
R-HSA-976991 Prolactin receptor ligands bind the prolactin receptor
R-HSA-1168767 JAK2 phosphorylates STAT1/STAT3
R-HSA-1168423 JAK2 phosphorylation of IRS-1/2
R-HSA-1168394 STAT5 tyrosine phosphorylation
R-HSA-1169192 PTP1B dephosphorylates GHR
R-HSA-1169210 PTP1B dephosphorylates JAK2
R-HSA-1169188 SHP1 (PTPN6) dephosphorylates JAK2
R-HSA-1675473 SH2B binds JAK2
R-HSA-1369080 PRLR binds STAT5
R-HSA-1369114 PRLR binds SHP2 (PTPN11)
R-HSA-1370500 PRLR binds SCF beta-TrCP complex
R-HSA-1671691 PRLR-bound STAT5 is phosphorylated
R-HSA-1369115 SHP2 is phosphorylated
R-HSA-982772 Growth hormone receptor signaling
R-HSA-1170546 Prolactin receptor signaling
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-168256 Immune System

-  Other Names for This Gene
  Alternate Gene Symbols: ENST00000323322.1, ENST00000323322.2, ENST00000323322.3, ENST00000323322.4, ENST00000323322.5, ENST00000323322.6, ENST00000323322.7, ENST00000323322.8, ENST00000323322.9, NM_000515, P01241, Q14405, Q16631, Q5EB53, Q9HBZ1, Q9UMJ7, Q9UNL5, SOMA_HUMAN, uc002jdj.1, uc002jdj.2, uc002jdj.3, uc002jdj.4, uc002jdj.5
UCSC ID: ENST00000323322.10
RefSeq Accession: NM_000515
Protein: P01241 (aka SOMA_HUMAN)
CCDS: CCDS11653.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.